Molecular Cytogenetics

  • Manfred Schwab
Part of the Pediatric Oncology book series (PEDIATRICO)


Comparative Genomic Hybridization Neuroblastoma Cell Line Gene Chromosome Molecular Cytogenetic Neuroblastoma Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abel F, Ejeskar K, Kogner P et al. (1999) Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24. Br J Cancer 81:1402–1409Google Scholar
  2. Alaminos M, Mora J, Cheung NK et al. (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63:4538–4546PubMedGoogle Scholar
  3. Alt FW, Kellems RE, Bertino JR et al. (1978) Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem 253:1357–1370PubMedGoogle Scholar
  4. Amler LC, Corvi R, Praml C et al. (1995) A reciprocal translocation (1;15) (36.2;q24) in a neuroblastoma cell line is accompanied by DNA duplication and may signal the site of a putative tumor suppressor-gene. Oncogene 10:1095–1101PubMedGoogle Scholar
  5. Amler LC, Bauer A, Corvi R et al. (2000) Identification and characterization of novel genes located at the t(1;15) (p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP. Genomics 64:195–202CrossRefPubMedGoogle Scholar
  6. Balaban-Malenbaum G, Gilbert F (1977) Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line. Science 198:739–741PubMedGoogle Scholar
  7. Barton K, Nucifora G (2000) AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia. Bioessays 22:214–218CrossRefPubMedGoogle Scholar
  8. Bauer A, Savelyeva L, Claas A et al (2001) Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosomes Cancer 31:228–239CrossRefPubMedGoogle Scholar
  9. Beheshti B, Braude I, Marrano P et al. (2003) Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 5:53–62PubMedGoogle Scholar
  10. Berwanger B, Hartmann O, Bergmann E et al. (2002) Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell 2:377–386CrossRefPubMedGoogle Scholar
  11. Biedler JL, Spengler BA (1976) A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture. J Natl Cancer Inst 57:683–695PubMedGoogle Scholar
  12. Biegel JA, White PS, Marshall HN et al. (1993) Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 52:176–182PubMedGoogle Scholar
  13. Bishop JM (1981) Enemies within: the genesis of retrovirus oncogenes. Cell 23:5–6CrossRefPubMedGoogle Scholar
  14. Bishop JM (1982) Retroviruses and cancer genes. Adv Cancer Res 37:1–32PubMedGoogle Scholar
  15. Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311PubMedGoogle Scholar
  16. Bown N, Pearson AD, Reid MM (1993) High incidence of constitutional balanced translocations in neuroblastoma. Cancer Genet Cytogenet 69:166–167CrossRefPubMedGoogle Scholar
  17. Bown N, Cotterill S, Lastowska M et al. (1999) Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340:1954–1961PubMedGoogle Scholar
  18. Bown N, Lastowska M, Cotterill S et al. (2001) 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 36:14–19CrossRefPubMedGoogle Scholar
  19. Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11:18–21CrossRefPubMedGoogle Scholar
  20. Brinkschmidt C, Christiansen H, Terpe HJ et al. (1997) Comparative genomic hybridization (CGH) analysis of neuroblastomas: an important methodological approach in paediatric tumour pathology. J Pathol 181:394–400CrossRefPubMedGoogle Scholar
  21. Brodeur GM, Sekhon G, Goldstein MN (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40:2256–2263PubMedGoogle Scholar
  22. Brodeur GM, Green AA, Hayes FA et al. (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41:4678–4686PubMedGoogle Scholar
  23. Caron H (1995) Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 24:215–221PubMedGoogle Scholar
  24. Caron H, van Sluis P, van Hoeve M et al. (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4:187–190CrossRefPubMedGoogle Scholar
  25. Caron H, van Sluis P, van Roy N et al. (1994) Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341–347PubMedGoogle Scholar
  26. Caron H, Peter M, van Sluis P et al (1995) Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4:535–539PubMedGoogle Scholar
  27. Caron H, van Sluis P, de Kraker J et al. (1996) Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334:225–230CrossRefPubMedGoogle Scholar
  28. Caron H, Spieker N, Godfried M et al. (2001) Chromosome bands 1p35–36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30:168–174CrossRefPubMedGoogle Scholar
  29. Caspersson T, Farber S, Foley GE et al. (1968) Chemical differentiation along metaphase chromosomes. Exp Cell Res 49:219–222CrossRefPubMedGoogle Scholar
  30. Cavenee WK, Dryja TP, Phillips RA et al. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779–784CrossRefPubMedGoogle Scholar
  31. Cavenee WK, Hansen MF, Nordenskjold M et al (1985) Genetic origin of mutations predisposing to retinoblastoma. Science 228:501–503PubMedGoogle Scholar
  32. Celeste A, Difilippantonio S, Difilippantonio MJ et al. (2003) H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114:371–383CrossRefPubMedGoogle Scholar
  33. Chatten J, Voorhess ML (1967) Familial neuroblastoma. Report of a kindred with multiple disorders, including neuroblastomas in four siblings. N Engl J Med 277:1230–1236PubMedGoogle Scholar
  34. Cheng NC, van Roy N, Chan A, Beitsma M et al. (1995) Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35–36 region, only one of which is associated with N-myc amplification. Oncogene 10:291–297PubMedGoogle Scholar
  35. Comings DE (1973) A general theory of carcinogenesis. Proc Natl Acad Sci USA 70:3324–3328PubMedGoogle Scholar
  36. Corvi R, Savelyeva L, Schwab M (1995) Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 55:3471–3474PubMedGoogle Scholar
  37. Cowel JK, Nowak NJ (2003) High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. Adv Cancer Res 90:91–125PubMedGoogle Scholar
  38. Cox D, Yuncken C, Spriggs AI (1965) Minute chromatin bodies in malignant tumours of childhood. Lancet 62:55–58CrossRefPubMedGoogle Scholar
  39. Cunsolo CL, Bicocchi MP, Petti AR, Tonini GP (2000) Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br J Cancer 83:1295–1300CrossRefPubMedGoogle Scholar
  40. Dalla-Favera R, Bregni M, Erikson J et al. (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824–7827PubMedGoogle Scholar
  41. Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79:3637–3640PubMedGoogle Scholar
  42. Dryja TP, Cavenee W, White R et al (1984) Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med 310:550–553PubMedGoogle Scholar
  43. Dumon-Jones V, Frappart PO, Tong WM et al. (2003) Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res 63:7263–7269PubMedGoogle Scholar
  44. Ejeskar K, Sjoberg RM, Abel F et al. (2001) Fine mapping of a tumour suppressor candidate gene region in 1p36.2–3, commonly deleted in neuroblastomas and germ cell tumours. Med Pediatr Oncol 36:61–66CrossRefPubMedGoogle Scholar
  45. Fan J, Tam P, Woude GV et al (2004) Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine. Proc Natl Acad Sci USA 101:1135–1140CrossRefPubMedGoogle Scholar
  46. Fero ML, Randel E, Gurley KE et al. (1998) The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177–180CrossRefPubMedGoogle Scholar
  47. Fong CT, Dracopoli NC, White PS et al. (1989) Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753–3757PubMedGoogle Scholar
  48. Fong CT, White PS, Peterson K et al. (1992) Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780–1785PubMedGoogle Scholar
  49. Friend SH, Bernards R, Rogelj S et al. (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646PubMedGoogle Scholar
  50. Fung YK, Murphree AL, T'Ang A et al. (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236:1657–1661PubMedGoogle Scholar
  51. Gehring M, Berthold F, Edler L et al. (1995) The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res 55:5366–5369PubMedGoogle Scholar
  52. Gennett IN, Cavenee WK (1990) Molecular genetics in the pathology and diagnosis of retinoblastoma. Brain Pathol 1:25–32PubMedGoogle Scholar
  53. Gilbert F, Balaban G, Moorhead P et al. (1982) Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet 7:33–42CrossRefPubMedGoogle Scholar
  54. Goss KH, Risinger MA, Kordich JJ et al. (2002) Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297:2051–2053CrossRefPubMedGoogle Scholar
  55. Gratacos M, Nadal M, Martin-Santos R et al. (2001) A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367–379CrossRefPubMedGoogle Scholar
  56. Groffen J, Stephenson JR, Heisterkamp N et al. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93–99CrossRefPubMedGoogle Scholar
  57. Gruber SB, Ellis NA, Scott KK et al. (2002) BLM heterozygosity and the risk of colorectal cancer. Science 297:2013CrossRefPubMedGoogle Scholar
  58. Guo C, White PS, Weiss MJ et al. (1999) Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18:4948–4957PubMedGoogle Scholar
  59. Guo C, White PS, Hogarty MD et al. (2000) Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas. Med Pediatr Oncol 35:544–546CrossRefPubMedGoogle Scholar
  60. Hecht F, Hecht BK, Northrup JC et al. (1982) Genetics of familial neuroblastoma: long-range studies. Cancer Genet Cytogenet 7:227–230CrossRefPubMedGoogle Scholar
  61. Heisterkamp N, Stephenson JR, Groffen J et al. (1983) Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239–242CrossRefPubMedGoogle Scholar
  62. Hiyama E, Hiyama K, Ohtsu K et al. (2001) Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Med Pediatr Oncol 36:67–74CrossRefPubMedGoogle Scholar
  63. Hogarty MD, Liu X, Guo C et al. (2000) Identificaiton of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 35:512–515CrossRefPubMedGoogle Scholar
  64. Hoshi M, Otagiri N, Shiwaku HO et al. (2000) Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss. Br J Cancer 82:1801–1807CrossRefPubMedGoogle Scholar
  65. Ide F, Kitada M, Sakashita H et al. (2003) p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol 163:1729–1733PubMedGoogle Scholar
  66. Inoue K, Zindy F, Randle DH et al. (2001) Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes Dev 15:2934–2939CrossRefPubMedGoogle Scholar
  67. Kallioniemi A, Kallioniemi OP, Sudar D et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821PubMedGoogle Scholar
  68. Kaneko Y, Knudson AG (2000) Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer 29:89–95CrossRefPubMedGoogle Scholar
  69. Khan J, Wei JS, Ringner M et al. (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673–679CrossRefPubMedGoogle Scholar
  70. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823PubMedGoogle Scholar
  71. Knudson AG Jr, Strong LC (1972) Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514–532PubMedGoogle Scholar
  72. Koiffmann CP, Gonzalez CH, Vianna-Morgante AM et al. (1995) Neuroblastoma in a boy with MCA/MR syndrome, deletion 11q, and duplication 12q. Am J Med Genet 58:46–49CrossRefPubMedGoogle Scholar
  73. Kucherlapati M, Yang K, Kuraguchi M et al. (2002) Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression. Proc Natl Acad Sci USA 99:9924–9929CrossRefPubMedGoogle Scholar
  74. Kushner BH, Gilbert F, Helson L (1986) Familial neuroblastoma. Case reports, literature review, and etiologic considerations. Cancer 57:1887–1893PubMedGoogle Scholar
  75. Kwabi-Addo B, Giri D, Schmidt K et al. (2001) Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 98:11563–11568CrossRefPubMedGoogle Scholar
  76. Lastowska M, Cotterill S, Pearson AD et al. (1997a) Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients.U.K.Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group. Eur J Cancer 33:1627–1633CrossRefPubMedGoogle Scholar
  77. Lastowska M, Nacheva E, McGuckin A et al. (1997b) Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Genes Chromosomes Cancer 18:162–169CrossRefPubMedGoogle Scholar
  78. Lastowska M, Roberts P, Pearson AD et al. (1997c) Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer 19:143–149CrossRefPubMedGoogle Scholar
  79. Lastowska M, Cotterill S, Bown N et al. (2002) Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosomes Cancer 34:428–436CrossRefPubMedGoogle Scholar
  80. Laureys G, Speleman F, Opdenakker G et al. (1990) Constitutional translocation t(1;17)(p36;q12–21) in a patient with neuroblastoma. Genes Chromosomes Cancer 2:252–254PubMedGoogle Scholar
  81. Lee WH, Bookstein R, Hong F et al. (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235:1394–1399PubMedGoogle Scholar
  82. Maris JM, Kyemba SM, Rebbeck TR et al. (1996) Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 56:3421–3425PubMedGoogle Scholar
  83. Maris JM, Weiss MJ, Guo C et al. (2000) Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol 18:1888–1899PubMedGoogle Scholar
  84. Maris JM, Guo C, White PS et al. (2001a) Allelic deletion at chromosome bands 11q14–23 is common in neuroblastoma. Med Pediatr Oncol 36:24–27CrossRefPubMedGoogle Scholar
  85. Maris JM, Guo C, Blake D et al. (2001b) Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol 36:32–36CrossRefPubMedGoogle Scholar
  86. Marshall B, Isidro G, Martins AG et al. (1997) Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: evidence for two deleted regions. Cancer Genet Cytogenet 96:134–139CrossRefPubMedGoogle Scholar
  87. Martinsson T, Sjoberg RM, Hedborg F et al. (1995) Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55:5681–5686PubMedGoogle Scholar
  88. Martinsson T, Sjoberg RM, Hallstensson K et al. (1997) Delimitation of a critical tumour suppressor region at distal 1p in neuroblasoma tumours. Eur J Cancer 33:1997–2001CrossRefPubMedGoogle Scholar
  89. Meddeb M, Danglot G, Chudoba I et al. (1996) Additional copies of a 25 Mb chromosomal region originating from 17q23.1–17qter are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 17:156–165CrossRefPubMedGoogle Scholar
  90. Mertens F, Johansson B, Hoglund M et al. (1997) Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 57:2765–2780PubMedGoogle Scholar
  91. Miller RW, Fraumeni JF Jr, Hill JA (1968) Neuroblastoma: epidemiologic approach to its origin. Am J Dis Child 115: 253–261PubMedGoogle Scholar
  92. Miyoshi H, Nakau M, Ishikawa TO et al. (2002) Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62:2261–2266PubMedGoogle Scholar
  93. Mora J, Cheung NK, Kushner BH et al. (2000) Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. J Mol Diagn 2:37–46PubMedGoogle Scholar
  94. Mora J, Gerald WL, Cheung NK (2003) Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma. Cancer Lett 197:119–124CrossRefPubMedGoogle Scholar
  95. Mosse Y, Greshock J, King A et al. (2003) Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. Lancet Oncol 4:769–771CrossRefPubMedGoogle Scholar
  96. Neel BG, Jhanwar SC, Chaganti RS et al. (1982) Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci USA 79:7842–7846PubMedGoogle Scholar
  97. Nowell PC, Hungerford DA (1960a) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25:85–109PubMedGoogle Scholar
  98. Nowell PC, Hungerford DA (1960b) A minute chromosome in human granulocytic leukemia. Science 132:1497–1499Google Scholar
  99. Ohira M, Kageyama H, Mihara M et al. (2000) Identification and characterization of a 500-kb homozygously deleted region at 1p36.2–p36.3 in a neuroblastoma cell line. Oncogene 19:4302–4307CrossRefPubMedGoogle Scholar
  100. Parada LF, Tabin CJ, Shih C et al. (1982) Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297:474–478CrossRefPubMedGoogle Scholar
  101. Perri P, Longo L, Cusano R et al. (2002) Weak linkage at 4p16 to predisposition for human neuroblastoma. Oncogene 21:8356–8360CrossRefPubMedGoogle Scholar
  102. Plantaz D, Mohapatra G, Matthay KK et al. (1997) Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81–89PubMedGoogle Scholar
  103. Plantaz D, Vandesompele J, van Roy N et al. (2001) Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer 91:680–686CrossRefPubMedGoogle Scholar
  104. Sandberg AA, Sakurai M, Holdsworth RN (1972) Chromosomes and causation of human cancer and leukemia. 8. DMS chromosomes in a neuroblastoma. Cancer 29:1671–1679PubMedGoogle Scholar
  105. Santos E, Tronick SR, Aaronson SA et al. (1982) T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB-and Harvey-MSV transforming genes. Nature 298:343–347CrossRefPubMedGoogle Scholar
  106. Satge D, Moore SW, Stiller CA et al. (2003) Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature. Cancer Genet Cytogenet 147:89–98CrossRefPubMedGoogle Scholar
  107. Savelyeva L, Claas A, Matzner I et al. (2001) Constitutional genomic instability with inversions, duplications, and amplifications in 9p23–24 in BRCA2 mutation carriers. Cancer Res 61:5179–5185PubMedGoogle Scholar
  108. Savelyeva L, Corvi R, Schwab M (1994) Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334–340PubMedGoogle Scholar
  109. Schleiermacher G, Peter M, Michon J et al. (1994) Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10:275–281PubMedGoogle Scholar
  110. Schleiermacher G, Delattre O, Peter M et al. (1996) Clinical relevance of loss heterozygosity of the short arm of chromosome 1 in neuroblastoma: a single-institution study. Int J Cancer 69:73–78CrossRefPubMedGoogle Scholar
  111. Schleiermacher G, Janoueix-Lerosey I, Combaret V et al. (2003) Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet 141:32–42CrossRefPubMedGoogle Scholar
  112. Schleiermacher G, Raynal V, Janoueix-Lerosey I et al. (2004) Variety and complexity of chromosome 17 translocations in neuroblastoma. Genes Chromosomes Cancer 39:143–150CrossRefPubMedGoogle Scholar
  113. Schwab M (1998) Amplification of oncogenes in human cancer cells. Bioessays 20:473–479CrossRefPubMedGoogle Scholar
  114. Schwab M, Alitalo K, Klempnauer KH et al. (1983a) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245–248CrossRefPubMedGoogle Scholar
  115. Schwab M, Alitalo K, Varmus HE et al. (1983b) A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature 303:497–501CrossRefPubMedGoogle Scholar
  116. Schwab M, Varmus HE, Bishop JM et al. (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308:288–291CrossRefPubMedGoogle Scholar
  117. Schwab M, Varmus HE, Bishop JM (1985) Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316:160–162CrossRefPubMedGoogle Scholar
  118. Schwab M, Praml C, Amler LC et al. (1996) Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 16:211–229CrossRefPubMedGoogle Scholar
  119. Schwab M, Westermann F, Hero B et al. (2003) Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4:472–480CrossRefPubMedGoogle Scholar
  120. Shaffer LG, Heilstedt HA (2001) Terminal deletion of 1p36. Lancet 358(Suppl):S9CrossRefPubMedGoogle Scholar
  121. Shapira SK, McCaskill C, Northrup H et al. (1997) Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 61:642–650PubMedGoogle Scholar
  122. Smits R, Ruiz P, Diaz-Cano S et al. (2000) E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology 119: 1045–1053CrossRefPubMedGoogle Scholar
  123. Song WJ, Sullivan MG, Legare RD et al. (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166–175CrossRefPubMedGoogle Scholar
  124. Sotiriou C, Khanna C, Jazaeri AA et al. (2002) Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. J Mol Diagn 4:30–36PubMedGoogle Scholar
  125. Sparkes RS, Sparkes MC, Wilson MG et al. (1980) Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science 208:1042–1044PubMedGoogle Scholar
  126. Sparkes RS, Murphree AL, Lingua RW et al. (1983) Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science 219:971–973PubMedGoogle Scholar
  127. Spieker N, Beitsma M, van Sluis P et al. (2001) Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1. Genes Chromosomes Cancer 31:172–181CrossRefPubMedGoogle Scholar
  128. Spitz R, Hero B, Westermann F et al. (2002) Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer 34:299–305CrossRefPubMedGoogle Scholar
  129. Spitz R, Hero B, Ernestus K et al. (2003) Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. Clin Cancer Res 9:4835–4840PubMedGoogle Scholar
  130. Spring K, Ahangari F, Scott SP et al. (2002) Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 32:185–190CrossRefPubMedGoogle Scholar
  131. Squire J, Gallie BL, Phillips RA (1985) A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 70:291–301CrossRefPubMedGoogle Scholar
  132. Srivastava M, Montagna C, Leighton X et al. (2003) Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse. Proc Natl Acad Sci USA 100:14287–14292CrossRefPubMedGoogle Scholar
  133. Stallings RL, Howard J, Dunlop A et al. (2003) Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma? Cancer Genet Cytogenet 140:133–137CrossRefPubMedGoogle Scholar
  134. Swanstrom R, Parker RC, Varmus HE et al. (1983) Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci USA 80:2519–2523PubMedGoogle Scholar
  135. Takayama H, Suzuki T, Mugishima et al. (1992) Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 7:1185–1189PubMedGoogle Scholar
  136. Takeda O, Homma C, Maseki N et al. (1994) There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10:30–39PubMedGoogle Scholar
  137. Takeda O, Handa M, Uehara T et al. (1996) An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas. Br J Cancer 74:1620–1626PubMedGoogle Scholar
  138. Takita J, Hayashi Y, Kohno T et al. (1995) Allelotype of neuroblastoma. Oncogene 11:1829–1834PubMedGoogle Scholar
  139. Thompson PM, Seifried BA, Kyemba SK et al. (2001) Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol 36:28–31CrossRefPubMedGoogle Scholar
  140. Tonini GP, Longo L, Coco S et al. (2003) Familial neuroblastoma: a complex heritable disease. Cancer Lett 197:41–45CrossRefPubMedGoogle Scholar
  141. Turleau C, de Grouchy J, Chavin-Colin F et al. (1985) Cytogenetic forms of retinoblastoma: their incidence in a survey of 66 patients. Cancer Genet Cytogenet 16:321–334CrossRefPubMedGoogle Scholar
  142. Van Roy N, Laureys G, Cheng NC et al. (1994) 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10:103–114PubMedGoogle Scholar
  143. Van Roy N, Cheng NC, Laureys G et al. (1995) Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer 31A:530–535PubMedGoogle Scholar
  144. Vandesompele J, van Roy N, van Gele M et al. (1998) Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23: 141–152CrossRefPubMedGoogle Scholar
  145. Vandesompele J, Speleman F, van Roy N et al. (2001) Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol 36:5–10CrossRefPubMedGoogle Scholar
  146. Varmus HE (1982) Form and function of retroviral proviruses. Science 216:812–820PubMedGoogle Scholar
  147. Venkatachalam S, Shi YP, Jones SN et al. (1998) Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 17:4657–4667CrossRefPubMedGoogle Scholar
  148. Vettenranta K, Aalto Y, Wikstrom S et al. (2001) Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma. Cancer Genet Cytogenet 125:125–130CrossRefPubMedGoogle Scholar
  149. Weith A, Martinsson T, Cziepluch C et al. (1989) Neuroblastoma consensus deletion maps to 1p36.1–2. Genes Chromosomes Cancer 1:159–166PubMedGoogle Scholar
  150. Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184:127–147CrossRefPubMedGoogle Scholar
  151. Wetmore C, Eberhart DE, Curran T (2000) The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. Cancer Res 60:2239–2246PubMedGoogle Scholar
  152. White PS, Maris JM, Beltinger C et al. (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2–36.3. Proc Natl Acad Sci USA 92: 5520–5524PubMedGoogle Scholar
  153. White PS, Thompson PM, Seifried BA et al. (2001) Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 36:37–41CrossRefPubMedGoogle Scholar
  154. Wu YQ, Heilstedt HA, Bedell JA et al. (1999) Molecular refinement of the 1p36 deletion syndrome reveals size diversity and a preponderance of maternally derived deletions. Hum Mol Genet 8:313–321CrossRefPubMedGoogle Scholar
  155. Yunis JJ (1983) The chromosomal basis of human neoplasia. Science 221:227–236PubMedGoogle Scholar
  156. Zhu Y, Ghosh P, Charnay P et al. (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920–922CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Manfred Schwab

There are no affiliations available

Personalised recommendations